|
Characteristicsa
|
AOR (95% CI)
|
p value
|
|---|
|
Age
| | |
|
19–29
|
1.00
| |
|
30–39
|
1.10 (0.47–2.57)
|
0.82
|
|
40–49
|
0.83 (0.37–1.90)
|
0.66
|
|
> 50
|
0.91 (0.39–2.12)
|
0.82
|
|
Gender
| | |
|
Woman
|
1.00
|
–
|
|
Man
|
1.40 (0.80–2.44)
|
0.24
|
|
Currently regularly housed
| | |
|
Yes
|
1.00
|
–
|
|
No
|
2.27 (1.20–4.27)
|
0.01
|
|
Opioid use (last 7 days)b
| | |
|
Yes
|
1.59 (0.87–2.88)
|
0.13
|
|
No
|
1.00
| |
|
Crystal meth use (last 7 days)
| | |
|
Yes
|
1.58 (0.86–2.88)
|
0.14
|
|
No
|
1.00
|
–
|
|
Crack/cocaine use (last 7 days)
| | |
|
Yes
|
2.10 (1.15–3.82)
|
0.02
|
|
No
|
1.00
|
–
|
|
Experienced an opioid or stimulant overdose (last 6 months)
| | |
|
Yes
|
1.71 (0.79–3.69)
|
0.17
|
|
No
|
1.00
|
–
|
- aFinal model is based on 306 observations after exclusion of missing responses and responses where ‘prefer not to say’ was indicated for independent variables
- bOpioids included heroin, fentanyl, morphine, hydromorphone (Dilaudid), methadone, and oxycodone
